Professor Andrew Roberts AM FAA FAHMS MBBS FRACP FRCPA PhD

Andrew Roberts AM is Cancer Theme co-Leader at the Walter & Eliza Hall Institute of Medical Research, a clinical haematologist at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre and the Metcalf Chair of Leukaemia Research at the University of Melbourne. A Past President of the Haematology Society of Australia and New Zealand and past Chair of the board of Cancer Council Victoria, he is currently a Director of the Australasian Leukaemia and Lymphoma Group (national clinical trials collaborative) and the Victorian Comprehensive Cancer Centre, and chairs the Life Saving Drug Program Expert Panel for the Australian government. He served on the PBAC from 2007 – 20018. His laboratory and clinical research pioneered the way for venetoclax, the first in a new class of targeted anti-cancer drug, to become a routine treatment for selected leukaemias. For this work, he and colleagues have received multiple awards, including the 2019 Prime Ministers Prize for Innovation in 2019.